Emend's Emergence
Mar 25, 2021•15 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
The Landmarks of OncoPharm series returns to discuss 2 pivotal trials that ushered in the age of aprepitant and NK-1 receptor anagonists for CINV.
Aprepitant in HEC: https://ascopubs.org/doi/pdf/10.1200/JCO.2003.01.095
Aprepitant in MEC: https://ascopubs.org/doi/pdf/10.1200/JCO.2005.09.050
For the best experience, listen in Metacast app for iOS or Android